Bristol Myers Squibb (NYSE: BMY) reported its second quarter 2025 earnings results today.
Total revenues inched up 1% year-over-year to $12.3 billion.
Net earnings attributable to BMS were $1.31 billion, or $0.64 per share, compared to $1.68 billion, or $0.83 per share, last year. Adjusted EPS decreased 29% to $1.46.
Bristol Myers Squibb expects full-year 2025 revenue to range between $46.5-47.5 billion and adjusted EPS to range between $6.35-6.65.
Advertising Disclosure: When you buy something by clicking links within this article, we may earn a small commission, but it...
Traders work on the floor at the New York Stock Exchange in New York City, U.S., Dec. 17, 2025. Brendan...
Recently, I wrote about how AI has already replaced 50,000 jobs this year. I use AI practically every day myself. So...
Advertising Disclosure: When you buy something by clicking links within this article, we may earn a small commission, but it...
Mustafa Hatipoglu | Anadolu | Getty ImagesVisa said on Thursday that it successfully completed hundreds of AI transactions as part...
Advertising Disclosure: When you buy something by clicking links within this article, we may earn a small commission, but it...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.
